Logo image
Abstract 194: Discordance in Apolipoprotein B vs. non-HDL-C and the Cholesterol-Enriched Phenotype: Insights From the National Health and Nutrition Examination Survey (NHANES) 2011-2012
Journal article   Peer reviewed

Abstract 194: Discordance in Apolipoprotein B vs. non-HDL-C and the Cholesterol-Enriched Phenotype: Insights From the National Health and Nutrition Examination Survey (NHANES) 2011-2012

Renato Quispe, Mariana Lazo, Allan Sniderman, Erin D Michos, Peter P Toth, Krishnaji Kulkarni, Steven R Jones and Seth S Martin
Arteriosclerosis, thrombosis, and vascular biology, v 36(suppl_1)
May 2016

Abstract

Background: Apolipoprotein B (apoB) levels in plasma are proportional to the number of all atherogenic, non-high-density lipoprotein (HDL) particles. Non-HDL-C concentration - the aggregate cholesterol carried by apoB-containing particles - is usually highly correlated with apoB levels. This study aimed to describe individuals with discordance between these lipid measures, especially apoB<non-HDL-C discordance, as there are few prior data on this cholesterol-enriched particle phenotype. Methods: We analyzed 2,804 participants of NHANES 2011-2012, a nationally representative US cross-sectional survey with direct apoB and standard lipid fasting measurements. We assigned population percentiles to non-HDL-C and apoB levels and created groups with 5-10 or >10 percentile units of discordantly low apoB (apoB<non-HDL-C: “cholesterol-enriched”) or high apoB (apoB>non-HDL-C: “cholesterol-depleted”). We compared lipids levels and other clinical characteristics across groups. Results: Discordance >5 percentile units was present in 50.9% of individuals. Compared with the cholesterol-depleted group, the cholesterol-enriched phenotype was characterized by a lower prevalence of obesity, diabetes, and hypertension. We found higher levels of low-density lipoprotein cholesterol (LDL-C), non-HDL-C, and HDL-C in cholesterol-enriched compared with cholesterol-depleted groups, whereas triglycerides were similar across groups. Lipid levels were consistent after excluding individuals on lipid-lowering therapy. Conclusion: Despite having higher levels of non-HDL-C and LDL-C, the cholesterol-enriched phenotype had a more favorable cardiovascular risk factor profile compared with the cholesterol-depleted phenotype. Triglycerides were notably low and similar across groups. Evaluation for discordance at both ends of the spectrum may provide additional prognostic information on CVD risk, but further outcomes studies are needed.

Metrics

9 Record Views

Details

Logo image